Trade IGC anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
IGC Pharma, Inc. (IGC) is trading at US$0.31, down 7.16% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$31.84M. Over the past 52 weeks, IGC has traded between US$0.24 and US$0.47. On Syfe you can trade IGC with $0 commission and add it to your watchlist.
| Previous close | US$0.33 |
|---|---|
| Market cap | US$31.84M |
| 52-week range | US$0.24 – US$0.47 |
| Volume | 882.11K |
| Exchange | US |
Add to Watchlist
Set Price Alert
IGC Pharma, Inc.
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
Year: 2006
IGC Pharma, Inc. (IGC) stock is trading at US$0.31, -7.16% from the previous close of US$0.33.
The market cap for IGC Pharma, Inc. (IGC) stock is approximately US$31.84M.
The 52-week high for IGC Pharma, Inc. (IGC) stock is US$0.47.
The 52-week low for IGC Pharma, Inc. (IGC) stock is US$0.24.
IGC Pharma, Inc. (IGC) does not currently pay a dividend.
Stay on top of IGC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
